FJ
Flynn James E disclosed a 5.3% stake in CLYM
Flynn James E reported owning 5.3% of Climb Bio, Inc. (CLYM) (3,070,000 shares) in a Schedule 13G filed Oct 28, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
Flynn James E reported owning 5.3% of Climb Bio, Inc. (CLYM) (3,070,000 shares) in a Schedule 13G filed Oct 28, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.